speb/financial-data huggingface dataset:
IBM.TO balance_sheet (quarterly, 2026-06-30) — Payables: 6418000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Payables And Accrued Expenses: 9843000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 3364000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Pretax Income: 2479000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Provision For Doubtful Accounts: 7000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Purchase Of Business: -15000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Purchase Of Intangibles: -154000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Purchase Of Investment: -1259000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Purchase Of PPE: -229000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Receivables: 13174000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Reconciled Cost Of Revenue: 6284000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Reconciled Depreciation: 1349000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Repayment Of Debt: -4213000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Repurchase Of Capital Stock: -115000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Research And Development: 2311000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Restricted Cash: 45000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Restructuring And Mergern Acquisition: 65000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Retained Earnings: 155937000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Salaries And Wages: 228000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Sale Of Business: 0.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Sale Of Investment: 1152000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Sale Of PPE: 23000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Selling And Marketing Expense: 384000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Selling General And Administration: 4532000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Share Issued: 942134390.00
IBM.TO income_statement (quarterly, 2026-06-30) — Special Income Charges: -65000000.00
IBM.TO cash_flow (quarterly, 2026-06-30) — Stock Based Compensation: 498000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Stockholders Equity: 34452000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Tangible Book Value: -54101000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Tax Effect Of Unusual Items: 3914078.26
IBM.TO income_statement (quarterly, 2026-06-30) — Tax Provision: 313000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Tax Rate For Calcs: 0.13
IBM.TO balance_sheet (quarterly, 2026-06-30) — Total Assets: 152099000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Total Capitalization: 90664000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Total Debt: 65272000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Total Equity Gross Minority Interest: 34541000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Total Expenses: 14317000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Total Liabilities Net Minority Interest: 117558000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Total Non Current Assets: 123700000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Total Non Current Liabilities Net Minority Interest: 81646000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Total Tax Payable: 2023000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Total Unusual Items: 31000000.00
IBM.TO income_statement (quarterly, 2026-06-30) — Total Unusual Items Excluding Goodwill: 31000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Treasury Stock: 170934000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Work In Process: 1425000000.00
IBM.TO balance_sheet (quarterly, 2026-06-30) — Working Capital: -7514000000.00
IBN balance_sheet (annual, 2022-03-31) — Accounts Payable: 27524211000.00
IBN balance_sheet (annual, 2022-03-31) — Accounts Receivable: 108389915000.00
IBN balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -104967406000.00
IBN cash_flow (annual, 2022-03-31) — Amortization Of Securities: 18320870000.00
IBN balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 4142273520000.00
IBN balance_sheet (annual, 2022-03-31) — Cash Equivalents: 162383872000.00
IBN balance_sheet (annual, 2022-03-31) — Commercial Paper: 90353072000.00
IBN balance_sheet (annual, 2022-03-31) — Current Debt: 90353072000.00
IBN balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 90353072000.00
IBN income_statement (annual, 2022-03-31) — Depreciation Amortization Depletion Income Statement: 13300074000.00
IBN income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 13300074000.00
IBN income_statement (annual, 2022-03-31) — Depreciation Income Statement: 13300074000.00
IBN balance_sheet (annual, 2022-03-31) — Derivative Product Liabilities: 112918929000.00
IBN income_statement (annual, 2022-03-31) — Gain On Sale Of Security: 25126881000.00
IBN balance_sheet (annual, 2022-03-31) — Gross PPE: 211021513000.00
IBN balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 20040640000.00
IBN balance_sheet (annual, 2022-03-31) — Long Term Provisions: 149289271000.00
IBN income_statement (annual, 2022-03-31) — Net Income Extraordinary: 0.00
IBN balance_sheet (annual, 2022-03-31) — Notes Receivable: 482956949000.00
IBN income_statement (annual, 2022-03-31) — Occupancy And Equipment: 26994748000.00
IBN cash_flow (annual, 2022-03-31) — Other Cash Adjustment Outside Changein Cash: -5586916000.00
IBN income_statement (annual, 2022-03-31) — Other Gand A: 9324939000.00
IBN balance_sheet (annual, 2022-03-31) — Other Payable: 337192443000.00
IBN balance_sheet (annual, 2022-03-31) — Other Properties: 116675686000.00
IBN income_statement (annual, 2022-03-31) — Other Special Charges: -56635000.00
IBN balance_sheet (annual, 2022-03-31) — Payables: 364716654000.00
IBN balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 364716654000.00
IBN balance_sheet (annual, 2022-03-31) — Prepaid Assets: 4460876000.00
IBN income_statement (annual, 2022-03-31) — Professional Expense And Contract Services Expense: 1926738000.00
IBN balance_sheet (annual, 2022-03-31) — Properties: 94345827000.00
IBN balance_sheet (annual, 2022-03-31) — Receivables: 591346864000.00
IBN income_statement (annual, 2022-03-31) — Rent And Landing Fees: 14085917000.00
IBN income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 14085917000.00
IBN income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 49011460000.00
IBN income_statement (annual, 2023-03-31) — +Total Revenue: 1355811552000.00
IBN balance_sheet (annual, 2023-03-31) — Accounts Payable: 33390137000.00
IBN balance_sheet (annual, 2023-03-31) — Accounts Receivable: 151100647000.00
IBN balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -113555439000.00
IBN balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 4890798331000.00
IBN income_statement (annual, 2023-03-31) — Basic Average Shares: 3483078183.00
IBN income_statement (annual, 2023-03-31) — Basic EPS: 97.72
IBN cash_flow (annual, 2023-03-31) — Beginning Cash Position: 1831259832000.00
IBN cash_flow (annual, 2023-03-31) — Capital Expenditure: -24676808000.00
IBN balance_sheet (annual, 2023-03-31) — Capital Stock: 13967750000.00
IBN balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1635673702000.00
IBN balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1635673702000.00
IBN cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -34794463000.00
IBN balance_sheet (annual, 2023-03-31) — Cash Equivalents: 222049738000.00
IBN balance_sheet (annual, 2023-03-31) — Cash Financial: 86812982000.00
IBN cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 247907176000.00
IBN cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -680053222000.00
IBN cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -37711921000.00
IBN cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -165971353000.00
IBN cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 277742529000.00
IBN cash_flow (annual, 2023-03-31) — Change In Other Working Capital: 1036377304000.00
IBN cash_flow (annual, 2023-03-31) — Change In Working Capital: -490783168000.00
IBN cash_flow (annual, 2023-03-31) — Changes In Cash: -469857967000.00
IBN balance_sheet (annual, 2023-03-31) — Commercial Paper: 98022849000.00
IBN balance_sheet (annual, 2023-03-31) — Common Stock: 13967750000.00
IBN cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -34794463000.00
IBN balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2144977893000.00
IBN cash_flow (annual, 2023-03-31) — Common Stock Issuance: 9420691000.00
IBN balance_sheet (annual, 2023-03-31) — Construction In Progress: 9009963000.00
IBN balance_sheet (annual, 2023-03-31) — Current Debt: 98022849000.00
IBN balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 98022849000.00
IBN cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 16351038000.00
IBN income_statement (annual, 2023-03-31) — Depreciation Amortization Depletion Income Statement: 15145592000.00
IBN cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 16351038000.00
IBN income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 15145592000.00
IBN income_statement (annual, 2023-03-31) — Depreciation Income Statement: 15145592000.00
IBN balance_sheet (annual, 2023-03-31) — Derivative Product Liabilities: 183764747000.00
IBN income_statement (annual, 2023-03-31) — Diluted Average Shares: 3557341137.00
IBN income_statement (annual, 2023-03-31) — Diluted EPS: 95.68
IBN income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 340366408000.00
IBN cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 3163063000.00
IBN cash_flow (annual, 2023-03-31) — End Cash Position: 1364564928000.00
IBN cash_flow (annual, 2023-03-31) — Financing Cash Flow: 247907176000.00
IBN cash_flow (annual, 2023-03-31) — Free Cash Flow: -62388729000.00
IBN cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 27053455000.00
IBN cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -542579000.00
IBN income_statement (annual, 2023-03-31) — Gain On Sale Of Security: -2504473000.00
IBN balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 2123401284000.00
IBN income_statement (annual, 2023-03-31) — General And Administrative Expense: 236541189000.00
IBN balance_sheet (annual, 2023-03-31) — Goodwill: 1013318000.00
IBN balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1013318000.00
IBN balance_sheet (annual, 2023-03-31) — Gross PPE: 232255438000.00
IBN income_statement (annual, 2023-03-31) — Insurance And Claims: 68215530000.00
IBN income_statement (annual, 2023-03-31) — Interest Expense: 505433879000.00
IBN income_statement (annual, 2023-03-31) — Interest Income: 1210668098000.00
IBN balance_sheet (annual, 2023-03-31) — Invested Capital: 3980072296000.00
IBN cash_flow (annual, 2023-03-31) — Investing Cash Flow: -680053222000.00
IBN balance_sheet (annual, 2023-03-31) — Investments And Advances: 4954939106000.00
IBN cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 9420691000.00
IBN cash_flow (annual, 2023-03-31) — Issuance Of Debt: 417361966000.00
IBN balance_sheet (annual, 2023-03-31) — Long Term Debt: 1737071554000.00
IBN balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1737071554000.00
IBN cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 417361966000.00
IBN cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -268917978000.00
IBN balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 64140775000.00
IBN balance_sheet (annual, 2023-03-31) — Long Term Provisions: 49946771000.00
IBN balance_sheet (annual, 2023-03-31) — Minority Interest: 66867526000.00
IBN income_statement (annual, 2023-03-31) — Minority Interests: -14246738000.00
IBN cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 9420691000.00
IBN balance_sheet (annual, 2023-03-31) — Net Debt: 199420701000.00
IBN income_statement (annual, 2023-03-31) — Net Income: 340366408000.00
IBN income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 340366408000.00
IBN income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 354613146000.00
IBN income_statement (annual, 2023-03-31) — Net Income Extraordinary: 0.00
IBN income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 340366408000.00
IBN income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 340366408000.00
IBN cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 458300782000.00
IBN income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 354613146000.00
IBN income_statement (annual, 2023-03-31) — Net Interest Income: 705234219000.00
IBN cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -658250590000.00
IBN cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 273280948000.00
IBN cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 148443988000.00
IBN balance_sheet (annual, 2023-03-31) — Net PPE: 118699999000.00
IBN cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -21802632000.00
IBN cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 124836960000.00
IBN balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2143964575000.00
IBN income_statement (annual, 2023-03-31) — Normalized Income: 339986602700.00
IBN balance_sheet (annual, 2023-03-31) — Notes Receivable: 497557667000.00
IBN income_statement (annual, 2023-03-31) — Occupancy And Equipment: 34644161000.00
IBN cash_flow (annual, 2023-03-31) — Operating Cash Flow: -37711921000.00
IBN cash_flow (annual, 2023-03-31) — Operating Gains Losses: 26510876000.00
IBN income_statement (annual, 2023-03-31) — Operating Revenue: 1355811552000.00
IBN balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 6982815731.00
IBN balance_sheet (annual, 2023-03-31) — Other Equity Interest: 7608859000.00
IBN income_statement (annual, 2023-03-31) — Other Gand A: 10188362000.00
IBN cash_flow (annual, 2023-03-31) — Other Non Cash Items: 55482301000.00
IBN income_statement (annual, 2023-03-31) — Other Non Interest Expense: 470631640000.00
IBN balance_sheet (annual, 2023-03-31) — Other Payable: 378867679000.00
IBN balance_sheet (annual, 2023-03-31) — Other Properties: 128905038000.00
IBN income_statement (annual, 2023-03-31) — Other Special Charges: -542579000.00
IBN balance_sheet (annual, 2023-03-31) — Payables: 412257816000.00
IBN balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 412257816000.00
IBN balance_sheet (annual, 2023-03-31) — Prepaid Assets: 20372701000.00
IBN income_statement (annual, 2023-03-31) — Pretax Income: 354613146000.00
IBN income_statement (annual, 2023-03-31) — Professional Expense And Contract Services Expense: 2020560000.00
IBN balance_sheet (annual, 2023-03-31) — Properties: 94340437000.00
IBN cash_flow (annual, 2023-03-31) — Purchase Of PPE: -24676808000.00
IBN balance_sheet (annual, 2023-03-31) — Receivables: 648658314000.00
IBN income_statement (annual, 2023-03-31) — Reconciled Depreciation: 16351038000.00
IBN income_statement (annual, 2023-03-31) — Rent And Landing Fees: 15846567000.00
IBN income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 15846567000.00
IBN cash_flow (annual, 2023-03-31) — Repayment Of Debt: -268917978000.00
IBN income_statement (annual, 2023-03-31) — Salaries And Wages: 152479092000.00
IBN cash_flow (annual, 2023-03-31) — Sale Of PPE: 2874176000.00
IBN income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 65407090000.00
IBN income_statement (annual, 2023-03-31) — Selling General And Administration: 301948279000.00
IBN balance_sheet (annual, 2023-03-31) — Share Issued: 6982815731.00
IBN income_statement (annual, 2023-03-31) — Special Income Charges: 542579000.00
IBN cash_flow (annual, 2023-03-31) — Stock Based Compensation: 5180508000.00
IBN balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2144977893000.00
IBN balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2143964575000.00
IBN income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 162773700.00
IBN income_statement (annual, 2023-03-31) — Tax Provision: 117934400000.00
IBN income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
IBN cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -108754258000.00
IBN balance_sheet (annual, 2023-03-31) — Total Assets: 19584904970000.00
IBN balance_sheet (annual, 2023-03-31) — Total Capitalization: 3882049447000.00
IBN balance_sheet (annual, 2023-03-31) — Total Debt: 1835094403000.00
IBN balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2211845419000.00
IBN balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 17373059551000.00
IBN income_statement (annual, 2023-03-31) — Total Unusual Items: 542579000.00
IBN income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 542579000.00
IBN balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 0.00
IBN income_statement (annual, 2024-03-31) — +Total Revenue: 1612101952000.00
IBN balance_sheet (annual, 2024-03-31) — Accounts Payable: 38985508000.00
IBN balance_sheet (annual, 2024-03-31) — Accounts Receivable: 208551090000.00
IBN balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -137517547000.00
IBN balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 6608098697000.00
IBN income_statement (annual, 2024-03-31) — Average Dilution Earnings: -688300000.00
IBN income_statement (annual, 2024-03-31) — Basic Average Shares: 3501849462.00
IBN income_statement (annual, 2024-03-31) — Basic EPS: 126.38
IBN cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1364564928000.00
IBN cash_flow (annual, 2024-03-31) — Capital Expenditure: -36785464000.00
IBN balance_sheet (annual, 2024-03-31) — Capital Stock: 14046790000.00
IBN balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 1901295868000.00
IBN balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 1901295868000.00
IBN cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -55985964000.00
IBN balance_sheet (annual, 2024-03-31) — Cash Equivalents: 295695710000.00
IBN balance_sheet (annual, 2024-03-31) — Cash Financial: 89558463000.00
IBN cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: 137645136000.00
IBN cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -1459310924000.00
IBN cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: 1572844783000.00
IBN cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 18818794000.00
IBN cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 302893172000.00
IBN cash_flow (annual, 2024-03-31) — Change In Other Working Capital: 2497285461000.00
IBN cash_flow (annual, 2024-03-31) — Change In Working Capital: 1036350579000.00
IBN cash_flow (annual, 2024-03-31) — Changes In Cash: 251178995000.00
IBN balance_sheet (annual, 2024-03-31) — Commercial Paper: 172960808000.00
IBN balance_sheet (annual, 2024-03-31) — Common Stock: 14046790000.00
IBN cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -55985964000.00
IBN balance_sheet (annual, 2024-03-31) — Common Stock Equity: 2561438346000.00
IBN cash_flow (annual, 2024-03-31) — Common Stock Issuance: 11708675000.00
IBN balance_sheet (annual, 2024-03-31) — Construction In Progress: 8831572000.00
IBN balance_sheet (annual, 2024-03-31) — Current Debt: 172960808000.00
IBN balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 172960808000.00
IBN cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 19958856000.00
IBN income_statement (annual, 2024-03-31) — Depreciation Amortization Depletion Income Statement: 19352106000.00
IBN cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 19958856000.00
IBN income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 19352106000.00
IBN income_statement (annual, 2024-03-31) — Depreciation Income Statement: 19352106000.00
IBN balance_sheet (annual, 2024-03-31) — Derivative Product Liabilities: 176519175000.00
IBN income_statement (annual, 2024-03-31) — Diluted Average Shares: 3571366486.00
IBN income_statement (annual, 2024-03-31) — Diluted EPS: 123.92
IBN income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 442563735000.00
IBN cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 4234435000.00
IBN cash_flow (annual, 2024-03-31) — End Cash Position: 1627689026000.00
IBN cash_flow (annual, 2024-03-31) — Financing Cash Flow: 137645136000.00
IBN balance_sheet (annual, 2024-03-31) — Foreign Currency Translation Adjustments: 19828929000.00
IBN cash_flow (annual, 2024-03-31) — Free Cash Flow: 1536059319000.00
IBN cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: 16172037000.00
IBN cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -144093000.00
IBN income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 30822095000.00
IBN balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 1112144138000.00
IBN income_statement (annual, 2024-03-31) — General And Administrative Expense: 304046347000.00
IBN balance_sheet (annual, 2024-03-31) — Goodwill: 24741619000.00
IBN balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 24741619000.00
IBN balance_sheet (annual, 2024-03-31) — Gross PPE: 278751882000.00
IBN income_statement (annual, 2024-03-31) — Insurance And Claims: 95126170000.00
IBN income_statement (annual, 2024-03-31) — Interest Expense: 741081627000.00
IBN income_statement (annual, 2024-03-31) — Interest Income: 1595159252000.00
IBN balance_sheet (annual, 2024-03-31) — Invested Capital: 4571425399000.00
IBN cash_flow (annual, 2024-03-31) — Investing Cash Flow: -1459310924000.00
IBN balance_sheet (annual, 2024-03-31) — Investments And Advances: 6623201036000.00
IBN cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 11708675000.00
IBN cash_flow (annual, 2024-03-31) — Issuance Of Debt: 391968191000.00
IBN balance_sheet (annual, 2024-03-31) — Long Term Debt: 1837026245000.00
IBN balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 1837026245000.00
IBN cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 391968191000.00
IBN cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -391468771000.00
IBN balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 15102339000.00
IBN balance_sheet (annual, 2024-03-31) — Long Term Provisions: 61602061000.00
IBN balance_sheet (annual, 2024-03-31) — Minority Interest: 138884162000.00
IBN income_statement (annual, 2024-03-31) — Minority Interests: -18241392000.00
IBN cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 11708675000.00
IBN balance_sheet (annual, 2024-03-31) — Net Debt: 108691185000.00
IBN income_statement (annual, 2024-03-31) — Net Income: 442563735000.00
IBN income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 442563735000.00
IBN income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 460805103000.00
IBN income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 442563735000.00
IBN income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 442563735000.00
IBN cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 596839961000.00
IBN income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 460805103000.00
IBN income_statement (annual, 2024-03-31) — Net Interest Income: 854077625000.00
IBN cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -1423224353000.00
IBN cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 181922425000.00
IBN cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: 499420000.00
IBN balance_sheet (annual, 2024-03-31) — Net PPE: 141234335000.00
IBN cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -36086571000.00
IBN cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 181423005000.00
IBN balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 2536696727000.00
IBN income_statement (annual, 2024-03-31) — Normalized Income: 442455809343.00
IBN balance_sheet (annual, 2024-03-31) — Notes Receivable: 500789314000.00
IBN income_statement (annual, 2024-03-31) — Occupancy And Equipment: 36171827000.00
IBN cash_flow (annual, 2024-03-31) — Operating Cash Flow: 1572844783000.00
IBN cash_flow (annual, 2024-03-31) — Operating Gains Losses: 16027944000.00
IBN income_statement (annual, 2024-03-31) — Operating Revenue: 1612101952000.00
IBN balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 7022335643.00
IBN cash_flow (annual, 2024-03-31) — Other Cash Adjustment Outside Changein Cash: 7710668000.00
IBN balance_sheet (annual, 2024-03-31) — Other Equity Interest: 14053180000.00
IBN cash_flow (annual, 2024-03-31) — Other Non Cash Items: 30074409000.00
IBN income_statement (annual, 2024-03-31) — Other Non Interest Expense: 570657210000.00
IBN balance_sheet (annual, 2024-03-31) — Other Payable: 767313759000.00
IBN balance_sheet (annual, 2024-03-31) — Other Properties: 166944799000.00
IBN income_statement (annual, 2024-03-31) — Other Special Charges: -144093000.00
IBN balance_sheet (annual, 2024-03-31) — Payables: 806299267000.00
IBN balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 806299267000.00
IBN balance_sheet (annual, 2024-03-31) — Prepaid Assets: 12595878000.00
IBN income_statement (annual, 2024-03-31) — Pretax Income: 615081303000.00
IBN income_statement (annual, 2024-03-31) — Professional Expense And Contract Services Expense: 1759687000.00
IBN balance_sheet (annual, 2024-03-31) — Properties: 102975511000.00
IBN cash_flow (annual, 2024-03-31) — Purchase Of PPE: -36785464000.00
IBN balance_sheet (annual, 2024-03-31) — Receivables: 709340404000.00
IBN income_statement (annual, 2024-03-31) — Reconciled Depreciation: 19958856000.00
IBN income_statement (annual, 2024-03-31) — Rent And Landing Fees: 17054394000.00
IBN income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 17054394000.00
IBN cash_flow (annual, 2024-03-31) — Repayment Of Debt: -391468771000.00
IBN balance_sheet (annual, 2024-03-31) — Retained Earnings: 898257800000.00
IBN income_statement (annual, 2024-03-31) — Salaries And Wages: 191865783000.00
IBN cash_flow (annual, 2024-03-31) — Sale Of PPE: 698893000.00
IBN income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 66279545000.00
IBN income_statement (annual, 2024-03-31) — Selling General And Administration: 370325892000.00
IBN balance_sheet (annual, 2024-03-31) — Share Issued: 7022335643.00
IBN income_statement (annual, 2024-03-31) — Special Income Charges: 144093000.00
IBN cash_flow (annual, 2024-03-31) — Stock Based Compensation: 7029081000.00
IBN balance_sheet (annual, 2024-03-31) — Stockholders Equity: 2561438346000.00
IBN balance_sheet (annual, 2024-03-31) — Tangible Book Value: 2536696727000.00
IBN income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 36167343.00
IBN income_statement (annual, 2024-03-31) — Tax Provision: 154276200000.00
IBN income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.25
IBN cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -133436047000.00
IBN balance_sheet (annual, 2024-03-31) — Total Assets: 23640630275000.00
IBN balance_sheet (annual, 2024-03-31) — Total Capitalization: 4398464591000.00
IBN balance_sheet (annual, 2024-03-31) — Total Debt: 2009987053000.00
IBN balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 2700322508000.00
IBN balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 20940307767000.00
IBN income_statement (annual, 2024-03-31) — Total Unusual Items: 144093000.00
IBN income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 144093000.00
IBN balance_sheet (annual, 2024-03-31) — Unrealized Gain Loss: -313803000.00
IBN income_statement (quarterly, 2024-09-30) — Net Income Extraordinary: 0.00
IBN income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
IBN income_statement (quarterly, 2024-09-30) — Total Unusual Items: 0.00
IBN income_statement (quarterly, 2024-09-30) — Total Unusual Items Excluding Goodwill: 0.00
IBN balance_sheet (quarterly, 2024-12-31) — Net Debt: 444948800000.00
IBN income_statement (annual, 2025-03-31) — +Total Revenue: 2047152637000.00
IBN income_statement (quarterly, 2025-03-31) — +Total Revenue: 567004500000.00
IBN balance_sheet (annual, 2025-03-31) — Accounts Payable: 42154332000.00
IBN balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 42154332000.00
IBN balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 238378033000.00
IBN balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -153977532000.00
IBN balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -153977532000.00
IBN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 609632791000.00
IBN balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 7228719024000.00
IBN balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 7228719024000.00
IBN income_statement (annual, 2025-03-31) — Average Dilution Earnings: -418000000.00
IBN income_statement (annual, 2025-03-31) — Basic Average Shares: 3523767948.00
IBN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 3532762951.00
IBN income_statement (annual, 2025-03-31) — Basic EPS: 144.82
IBN income_statement (quarterly, 2025-03-31) — Basic EPS: 38.22
IBN cash_flow (annual, 2025-03-31) — Beginning Cash Position: 1627689026000.00
IBN cash_flow (annual, 2025-03-31) — Capital Expenditure: -47700055000.00
IBN balance_sheet (annual, 2025-03-31) — Capital Stock: 14245974000.00
IBN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 14245974000.00
IBN balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 2383044013000.00
IBN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2383044013000.00
IBN balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 2383044013000.00
IBN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 2383044013000.00
IBN cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -70412665000.00
IBN balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 155954627000.00
IBN balance_sheet (annual, 2025-03-31) — Cash Financial: 1202409100000.00
IBN balance_sheet (quarterly, 2025-03-31) — Cash Financial: 64936822000.00
IBN cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 55892342000.00
IBN cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -772883605000.00
IBN cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: 1228052582000.00
IBN cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -5176415000.00
IBN cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: 229962676000.00
IBN cash_flow (annual, 2025-03-31) — Change In Other Working Capital: 2055588659000.00
IBN cash_flow (annual, 2025-03-31) — Change In Working Capital: 640177434000.00
IBN cash_flow (annual, 2025-03-31) — Changes In Cash: 511061319000.00
IBN balance_sheet (annual, 2025-03-31) — Commercial Paper: 226221340000.00
IBN balance_sheet (quarterly, 2025-03-31) — Commercial Paper: 226221340000.00
IBN balance_sheet (annual, 2025-03-31) — Common Stock: 14246000000.00
IBN balance_sheet (quarterly, 2025-03-31) — Common Stock: 14245974000.00
IBN cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -70412665000.00
IBN balance_sheet (annual, 2025-03-31) — Common Stock Equity: 3139059061000.00
IBN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 3139059061000.00
IBN cash_flow (annual, 2025-03-31) — Common Stock Issuance: 14375199000.00
IBN balance_sheet (annual, 2025-03-31) — Construction In Progress: 10732726000.00
IBN balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 10732726000.00
IBN balance_sheet (annual, 2025-03-31) — Current Debt: 226221340000.00
IBN balance_sheet (quarterly, 2025-03-31) — Current Debt: 226221340000.00
IBN balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 226221340000.00
IBN balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 226221340000.00
IBN cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 26903750000.00
IBN income_statement (annual, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 26273160000.00
IBN cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 26903750000.00
IBN income_statement (annual, 2025-03-31) — Depreciation Income Statement: 26273160000.00
IBN balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 185821678000.00
IBN balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 185821678000.00
IBN income_statement (annual, 2025-03-31) — Diluted Average Shares: 3583641220.00
IBN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 3583391720.00
IBN income_statement (annual, 2025-03-31) — Diluted EPS: 142.28
IBN income_statement (quarterly, 2025-03-31) — Diluted EPS: 37.68
IBN income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 509874000000.00
IBN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 135022200000.00
IBN cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 1484292000.00
IBN cash_flow (annual, 2025-03-31) — End Cash Position: 2140234637000.00
IBN cash_flow (annual, 2025-03-31) — Financing Cash Flow: 55892342000.00
IBN balance_sheet (quarterly, 2025-03-31) — Fixed Assets Revaluation Reserve: 37795163000.00
IBN balance_sheet (annual, 2025-03-31) — Foreign Currency Translation Adjustments: 21313221000.00
IBN balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: 21313221000.00
IBN cash_flow (annual, 2025-03-31) — Free Cash Flow: 1180352527000.00
IBN cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -1023190000.00
IBN cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: -439077000.00
IBN balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 1310631193000.00
IBN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3104114700000.00
IBN income_statement (annual, 2025-03-31) — General And Administrative Expense: 500478020000.00
IBN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 287304400000.00
IBN balance_sheet (annual, 2025-03-31) — Goodwill: 84594312000.00
IBN balance_sheet (quarterly, 2025-03-31) — Goodwill: 84594300000.00
IBN balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 84594312000.00
IBN balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 84594300000.00
IBN balance_sheet (annual, 2025-03-31) — Gross PPE: 322834492000.00
IBN balance_sheet (quarterly, 2025-03-31) — Gross PPE: 322834492000.00
IBN income_statement (annual, 2025-03-31) — Insurance And Claims: 241165358000.00
IBN income_statement (quarterly, 2025-03-31) — Insurance And Claims: 229334300000.00
IBN income_statement (annual, 2025-03-31) — Interest Expense: 890276529000.00
IBN income_statement (quarterly, 2025-03-31) — Interest Expense: 230473200000.00
IBN income_statement (annual, 2025-03-31) — Interest Income: 1863314641000.00
IBN income_statement (quarterly, 2025-03-31) — Interest Income: 483869200000.00
IBN balance_sheet (annual, 2025-03-31) — Invested Capital: 5175556538000.00
IBN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 5175556538000.00
IBN cash_flow (annual, 2025-03-31) — Investing Cash Flow: -772883605000.00
IBN balance_sheet (annual, 2025-03-31) — Investments And Advances: 7251369065000.00
IBN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 7251369065000.00
IBN cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 14375199000.00
IBN cash_flow (annual, 2025-03-31) — Issuance Of Debt: 404464948000.00
IBN balance_sheet (annual, 2025-03-31) — Long Term Debt: 1810276137000.00
IBN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1810276137000.00
IBN balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2188834400000.00
IBN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2188834400000.00
IBN cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 404464948000.00
IBN cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -399331062000.00
IBN balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 22650041000.00
IBN balance_sheet (annual, 2025-03-31) — Long Term Provisions: 68748943000.00
IBN balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 68748943000.00
IBN balance_sheet (annual, 2025-03-31) — Minority Interest: 148367400000.00
IBN balance_sheet (quarterly, 2025-03-31) — Minority Interest: 148367400000.00
IBN income_statement (annual, 2025-03-31) — Minority Interests: -35401801000.00
IBN income_statement (quarterly, 2025-03-31) — Minority Interests: -8514700000.00
IBN cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 14375199000.00
IBN balance_sheet (annual, 2025-03-31) — Net Debt: 48599800000.00
IBN balance_sheet (quarterly, 2025-03-31) — Net Debt: 48599800000.00
IBN income_statement (annual, 2025-03-31) — Net Income: 510291955000.00
IBN income_statement (quarterly, 2025-03-31) — Net Income: 135022200000.00
IBN income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 510291955000.00
IBN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 135022200000.00
IBN income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 545693565000.00
IBN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 143536900000.00
IBN income_statement (annual, 2025-03-31) — Net Income Extraordinary: 0.00
IBN income_statement (quarterly, 2025-03-31) — Net Income Extraordinary: 0.00
IBN income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 510291955000.00
IBN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 135022200000.00
IBN income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 510291955000.00
IBN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 135022200000.00
IBN cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 694640235000.00
IBN income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 545693565000.00
IBN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 143536900000.00
IBN income_statement (annual, 2025-03-31) — Net Interest Income: 973038112000.00
IBN income_statement (quarterly, 2025-03-31) — Net Interest Income: 253396000000.00
IBN cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -725829665000.00
IBN cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 111929808000.00
IBN cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 5133886000.00
IBN balance_sheet (annual, 2025-03-31) — Net PPE: 168856960000.00
IBN balance_sheet (quarterly, 2025-03-31) — Net PPE: 158124234000.00
IBN cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -47053940000.00
IBN cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 106795922000.00
IBN balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 3054464749000.00
IBN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 3054464749000.00
IBN income_statement (annual, 2025-03-31) — Normalized Income: 509963752598.29
IBN income_statement (quarterly, 2025-03-31) — Normalized Income: 135022200000.00
IBN balance_sheet (annual, 2025-03-31) — Notes Receivable: 463393153000.00
IBN balance_sheet (quarterly, 2025-03-31) — Notes Receivable: 463393153000.00
IBN income_statement (annual, 2025-03-31) — Occupancy And Equipment: 38200665000.00
IBN cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1228052582000.00
IBN cash_flow (annual, 2025-03-31) — Operating Gains Losses: -1462267000.00
IBN income_statement (annual, 2025-03-31) — Operating Revenue: 2047152637000.00
IBN income_statement (quarterly, 2025-03-31) — Operating Revenue: 567004500000.00
IBN balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 7121927830.00
IBN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 7121927830.00
IBN cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 0.00
IBN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 1229322416000.00
IBN balance_sheet (annual, 2025-03-31) — Other Equity Interest: 20698400000.00
IBN balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 20698433000.00
IBN cash_flow (annual, 2025-03-31) — Other Non Cash Items: -215943000.00
IBN income_statement (annual, 2025-03-31) — Other Non Interest Expense: 658084121000.00
IBN income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 79172000000.00
IBN balance_sheet (quarterly, 2025-03-31) — Other Payable: 708966096000.00
IBN balance_sheet (annual, 2025-03-31) — Other Properties: 197275838000.00
IBN balance_sheet (quarterly, 2025-03-31) — Other Properties: 197275838000.00
IBN income_statement (annual, 2025-03-31) — Other Special Charges: -439077000.00
IBN balance_sheet (quarterly, 2025-03-31) — Payables: 751120428000.00
IBN balance_sheet (annual, 2025-03-31) — Payables And Accrued Expenses: 751120428000.00
IBN balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 751120428000.00
IBN balance_sheet (annual, 2025-03-31) — Prepaid Assets: 6929092000.00
IBN balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 6929092000.00
IBN income_statement (annual, 2025-03-31) — Pretax Income: 730041865000.00
IBN income_statement (quarterly, 2025-03-31) — Pretax Income: 191430000000.00
IBN balance_sheet (annual, 2025-03-31) — Properties: 114825928000.00
IBN balance_sheet (quarterly, 2025-03-31) — Properties: 114825928000.00
IBN cash_flow (annual, 2025-03-31) — Purchase Of PPE: -47700055000.00
IBN balance_sheet (quarterly, 2025-03-31) — Receivables: 701771186000.00
IBN income_statement (annual, 2025-03-31) — Reconciled Depreciation: 26903750000.00
IBN cash_flow (annual, 2025-03-31) — Repayment Of Debt: -399331062000.00
IBN balance_sheet (annual, 2025-03-31) — Retained Earnings: 1183850670000.00
IBN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1183850670000.00
IBN income_statement (annual, 2025-03-31) — Salaries And Wages: 236508575000.00
IBN income_statement (quarterly, 2025-03-31) — Salaries And Wages: 57970100000.00
IBN cash_flow (annual, 2025-03-31) — Sale Of PPE: 646115000.00
IBN income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 52494869000.00
IBN income_statement (annual, 2025-03-31) — Selling General And Administration: 552972889000.00
IBN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 287304400000.00
IBN balance_sheet (annual, 2025-03-31) — Share Issued: 7121927830.00
IBN balance_sheet (quarterly, 2025-03-31) — Share Issued: 7121927830.00
IBN income_statement (annual, 2025-03-31) — Special Income Charges: 439077000.00
IBN income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
IBN cash_flow (annual, 2025-03-31) — Stock Based Compensation: 7901495000.00
IBN balance_sheet (annual, 2025-03-31) — Stockholders Equity: 3139059061000.00
IBN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 3139059061000.00
IBN balance_sheet (annual, 2025-03-31) — Tangible Book Value: 3054464800000.00
IBN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 3054464749000.00
IBN income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 110874598.29
IBN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IBN income_statement (annual, 2025-03-31) — Tax Provision: 184348300000.00
IBN income_statement (quarterly, 2025-03-31) — Tax Provision: 47893100000.00
IBN income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.25
IBN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
IBN cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -181164596000.00
IBN balance_sheet (annual, 2025-03-31) — Total Assets: 26422414134000.00
IBN balance_sheet (quarterly, 2025-03-31) — Total Assets: 26422414100000.00
IBN balance_sheet (annual, 2025-03-31) — Total Capitalization: 4949335198000.00
IBN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4949335198000.00
IBN balance_sheet (annual, 2025-03-31) — Total Debt: 2036497477000.00
IBN balance_sheet (quarterly, 2025-03-31) — Total Debt: 2036497477000.00
IBN balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 3287426422000.00
IBN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 3287426422000.00
IBN balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 23134987600000.00
IBN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 23134987600000.00
IBN income_statement (annual, 2025-03-31) — Total Unusual Items: 439077000.00
IBN income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
IBN income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 439077000.00
IBN income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
IBN balance_sheet (annual, 2025-03-31) — Unrealized Gain Loss: 22200393000.00
IBN balance_sheet (quarterly, 2025-03-31) — Unrealized Gain Loss: 22200393000.00
IBN income_statement (quarterly, 2025-06-30) — +Total Revenue: 356136100000.00
IBN balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 9058843000000.00
IBN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 3564037855.00
IBN income_statement (quarterly, 2025-06-30) — Basic EPS: 38.04
IBN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 14273200000.00
IBN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 1968211700000.00
IBN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 1968211700000.00
IBN balance_sheet (quarterly, 2025-06-30) — Cash Financial: 965127400000.00
IBN balance_sheet (quarterly, 2025-06-30) — Common Stock: 14273200000.00
IBN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 3296154100000.00
IBN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 3623089257.00
IBN income_statement (quarterly, 2025-06-30) — Diluted EPS: 37.42
IBN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 135576000000.00
IBN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 3260455500000.00
IBN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 66382200000.00
IBN balance_sheet (quarterly, 2025-06-30) — Goodwill: 84594300000.00
IBN balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 84594300000.00
IBN income_statement (quarterly, 2025-06-30) — Insurance And Claims: 158723600000.00
IBN income_statement (quarterly, 2025-06-30) — Interest Expense: 230900600000.00
IBN income_statement (quarterly, 2025-06-30) — Interest Income: 490799600000.00
IBN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 5447643800000.00
IBN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 9058843000000.00
IBN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 2151489700000.00
IBN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2151489700000.00
IBN balance_sheet (quarterly, 2025-06-30) — Minority Interest: 158136700000.00
IBN income_statement (quarterly, 2025-06-30) — Minority Interests: -8987300000.00
IBN balance_sheet (quarterly, 2025-06-30) — Net Debt: 183278000000.00
IBN income_statement (quarterly, 2025-06-30) — Net Income: 135576000000.00
IBN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 135576000000.00
IBN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 144563300000.00
IBN income_statement (quarterly, 2025-06-30) — Net Income Extraordinary: 0.00